No complaints, picked these up at 7.2cts - every chemist i go into the products are right behind the cashier plus the momentum for improving gut health continues to gain momentum
the ipo price was 20cts but that was poorly executed with too much loose stock in the hands of seed investors and service providers - that's well and truly been absorbed, and the management team have just continued to kick goal after goal to accelerate revenue momentum - a multi bagger in the making
Ann: FY24 Revenue Guidance Upgrade to $12.5M, page-8
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.0¢ |
Change
0.015(2.26%) |
Mkt cap ! $149.0M | |||
| Open | High | Low | Value | Volume |
| 66.5¢ | 69.0¢ | 66.0¢ | $173.2K | 255.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 46226 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 69.0¢ | 83602 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| BIO (ASX) Chart |